UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005184
Receipt number R000006155
Scientific Title Clinical efficacy and biomarker assessment of Capecitabine plus oxaliplatin (XELOX) in combination with Bevacizumab as second-line therapy in patients with advanced or recurrent colorectal cancer after failure to irinotecan. Multi-center phase II Study.
Date of disclosure of the study information 2011/03/03
Last modified on 2019/09/17 17:42:53

No. Disposal Last modified on Item of update
1 Insert 2011/03/03 17:23:21
2 Update 2015/03/11 11:17:47 Email
Last name of contact person
Last name of contact person
Email
Name of person sending information
Name of person sending information
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2015/03/11 12:24:15 Last follow-up date
4 Update 2019/09/17 17:42:53 Recruitment status
Date of IRB